Diabetic Cardiovascular Disease Induced by Oxidative Stress.
Kayama Y, Raaz U, Jagger A, Adam M, Schellinger IN, Sakamoto M, Suzuki H, Toyama K, Spin JM, Tsao PS. · 2015
Read Diabetic Cardiovascular Disease Induced by Oxidative Stress. by Kayama Y, Raaz U, Jagger A, Adam M, Schellinger IN, Sakamoto M, Suzuki H, Toyama K, Spin JM, Tsao PS. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4632800.txt.
Introduction
How oxidative stress drives cardiovascular disease in diabetes is the subject of a 2015 review by Yuji Kayama and colleagues. Heart and vessel disease is the top cause of illness and death in people with diabetes. Oxidative stress comes from excess reactive oxygen species, unstable molecules that damage tissue. The review appeared in the International Journal of Molecular Sciences.
High blood sugar and weak antioxidant defences keep these damaging molecules elevated in diabetes. Over time they fuel inflammation and scarring in the heart and vessels, feeding coronary disease, heart muscle thickening, and heart failure. Markers of oxidative stress run high in patients. The authors gather the latest findings on diabetic heart and vessel damage and argue that understanding this pathway is key to preventing complications.
Catalog record
| CREATOR | Kayama Y, Raaz U, Jagger A, Adam M, Schellinger IN, Sakamoto M, Suzuki H, Toyama K, Spin JM, Tsao PS. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 92 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Diabetic Cardiovascular Disease Induced by Oxidative Stress By Yosuke Kayama, Uwe Raaz, Ann Jagger, Matti Adam, Isabel N Schellinger, Masaya Sakamoto, Hirofumi Suzuki, Kensuke Toyama, Joshua M Spin, Philip S Tsao, Gabor Csanyi Published in: International Journal of Molecular Sciences DOI: 10.3390/ijms161025234 ABSTRACT Abstract Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among patients with diabetes mellitus (DM). DM can lead to multiple cardiovascular complications, including coronary artery disease (CAD), cardiac hypertrophy, and heart failure (HF). HF represents one of the most common causes of death in patients with DM and results from DM-induced CAD and diabetic cardiomyopathy. Oxidative stress is closely associated with the pathogenesis of DM and results from overproduction of reactive oxygen species (ROS). ROS overproduction is associated with hyperglycemia and metabolic disorders, such as impaired antioxidant function in conjunction with impaired antioxidant activity. Long-term exposure to oxidative stress in DM induces chronic inflammation and fibrosis in a range of tissues, leading to formation and progression of disease states in these tissues. Indeed, markers for oxidative stress are overexpressed in patients with DM, suggesting that increased ROS may be primarily responsible for the development of diabetic complications. Therefore, an understanding of the pathophysiological mechanisms mediated by oxidative stress is crucial to the prevention and treatment of diabetes-induced CVD. The current review focuses on the relationship between diabetes-induced CVD and oxidative stress, while highlighting the latest insights into this relationship from findings on diabetic heart and vascular disease. Keywords: diabetes mellitus, oxidative stress, cardiovascular disease, diabetic heart, diabetic vascular disease 1. INTRODUCTION The worldwide incidence of diabetes mellitus (DM) has recently increased rapidly due to lifestyle changes, with DM projected to affect over 300 million people by 2015 [1]. DM is associated with a wide array of complications, and the associated decrease in quality of life (QOL) of affected patients, thus contributing to the staggering increase in healthcare expenditure. DM is thought to cause not only microangiopathy (associated with the three major diabetic complications, namely diabetic retinopathy, nephropathy and neuropathy) but to constitute a major risk factor for macroangiopathy, such as coronary artery disease (CAD) and cerebrovascular disease [2,3]. The Framingham and MERIT studies demonstrate that patients with DM are two to four times more likely to develop CVD, and have three times higher overall mortality rate compared to those without DM [4,5,6]. It is also shown that the risk for HF is increased in DM patients even after adjustment for CAD and hypertension [5]. It is also known that oxidative stress and inflammation play a key role in the pathogenesis and progression of diabetes-induced CVD, where the increased expression of inflammatory proteins or cytokines such as C-reactive protein (CRP) or oxidative stress-related proteins is shown to serve as a biomarker for the onset of CVD and HF [7]. Thus, it is of great concern that CVD is far more common in patients with DM than the non-diabetic population. Furthermore, oxidative stress is reported to be increased in patients with DM and animal models of DM, with increases noted in reactive oxygen species (ROS) in rat models of DM [8], as well as in 8-hydroxy-deoxyguanosine (8-OHdG) as a marker of DNA oxidation disorder, 8-iso-prostaglandin F2a resulting from arachidonic acid peroxidization in blood and urine, and serum peroxidized fat and oxidized low-density lipoproteins (LDL) in patients with DM [9,10,11,12]. It is also recently shown that pancreatic β-cell loss is characteristic of both type 1 and 2 DM and is primarily due to cell damage and death resulting from increased inflammation and oxidative stress at the tissue level [13,14]. Again, oxidative stress is thought to be a major factor contributing to the development and progression of diabetic complications, which is also closely associated with insulin resistance and impaired insulin secretion resulting in the development of DM. Thus, oxidative stress in DM constitutes an important factor implicated not only in the development of diabetic complications but also in the development of DM itself. The present review provides an overview of oxidative stress followed by a discussion of oxidative stress in relation to the diabetic heart or diabetic heart disease (DHD) and diabetic vascular disease (DVD) as diabetic cardiovascular complications. 2. OXIDATIVE STRESS: AN OVERVIEW Oxidative stress is defined as a state in which ROS overproduction in vivo exceeds the buffering capacity of antioxidant enzymes and antioxidants thus resulting in a local imbalance between ROS production and destruction. When available in appropriate amounts, ROS are shown to act as signal transduction molecules providing cell protection, while, in contrast, when available in large excess, they are shown to modify/degenerate biological macromolecules, e.g., nucleic acid (DNA degeneration), lipids (lipid oxidation), and proteins (membrane protein degeneration), thus inducing cell dysfunction or death. ROS are a group of short-lived, low-molecular-weight compounds derived from oxygen inhaled by aerobic respiration and through a variety of reactions oxygen undergoes in vivo, and include superoxide anion (·O2−), hydrogen peroxide (H2O2), hydroxyl radical (·OH−), and peroxynitrite (ONOO−) (Figure 1). While ROS are being constantly produced in vivo, normally, their production is regulated to remain below a certain level by antioxidant enzymes in vivo, such as superoxide dismutase (SOD), glutathione peroxidase (GSHPx) or catalase (Figure 1) or by antioxidants, such as glutathione and ascorbic acid (vitamin C), In contrast certain exposures, such as ultraviolet (UV) radiation, chemicals, or inflammatory cytokines lead to increased intracellular ROS. Excess ROS production, that exceeds the buffering capacity of antioxidant enzymes and antioxidants, tips the balance toward a more oxidative state. [Figure: Major generative and eliminative reaction of reactive oxygen species (ROS). Sequential reduction of oxygen resulting in ROS generation, and major ROS generative reaction and eliminative reaction are shown. Superoxide dismutase (SOD) catalyzes the dismutation of superoxide (·O2−) into H2O2 and O2. Catalase dismutates H2O2 into water and molecular oxygen. Glutathione peroxidase (GSHPx) eliminates H2O2 by using GR for another substrate, and generates water. Disproportionation reaction, Harber–Weiss reaction and Fenton reaction are shown. Superoxide anion (·O2−), hydrogen peroxide (H2O2), hydroxyl radical (·OH), Peroxynitrite (ONOO−), Superoxide dismutase (SOD), Glutathione peroxidase (GSHPx), Glutathione (GSH), Glutathione–S–S–Glutathione (GSSG), Glutathione Reductase (GR), Nicotinamide adenine dinucleotide phosphate (NADPH), Nitric Oxide (NO).] Sources of ROS production in the human tissue include the mitochondrial electron transport system, NADPH oxidases, xanthine oxidase, uncoupled nitric oxide synthase (NOS), and arachidonic acid metabolism pathways (12/15 lipoxygenase), but they vary in their pathological role and importance depend on the disease and the organ. Of these, the mitochondrial electron transport chain, NADPH oxidase, and xanthine oxidase are thought to be primary sources of ROS production in cardiomyocytes [15], while NADPH oxidase, xanthine oxidase, and uncoupled NOS are thought to be primary sources of ROS production in vascular cells [16] (Figure 2). [Figure: Sources of ROS in the diabetic heart. NADPH oxidase, mitochondria respiratory chain, Arachidonic acid (AA), xanthine oxidase and uncoupling of NOS are major source of ROS in the diabetic heat. Activated NADPH, dysfunctional mitochondrial respiratory chain, decreased availability of tetrahydrobiopterin (BH4) in uncoupled eNOS, activated 12/15-LOX pathway in AA and xanthine oxidase generate superoxide anion (·O2−) in the heart. SOD isoforms, MnSOD, and CuZn SOD dismutate superoxide anion (·O2−) to produce hydrogen peroxide (H2O2). Superoxide anion (·O2−), hydrogen peroxide (H2O2), hydroxyl radical (·OH), endothelial nitric oxide synthase (eNOS), superoxide dismutase (SOD), dihydrobiopterin (BH2), tetrahydrobiopterin